×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Growth Deficiency and Mental Retardation with Facial Dysmorphism
0.800
Biomarker
CTD_human
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Leukemia, Myelocytic, Acute
0.600
Biomarker
CTD_human
This transcriptomics-based characterization and chemical interrogation of human MLL -rearranged AML was a valuable approach for identifying complementary features that define this disease.
26237430
2015
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Leukemia, Myelocytic, Acute
0.600
Biomarker
CTD_human
In this study, we have identified a fusion partner of MLL in a 10-year-old female who developed therapy-related acute myeloid leukemia 17 months after treatment for Hodgkin's disease.
10339604
1999
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Childhood Acute Lymphoblastic Leukemia
0.400
Biomarker
CTD_human
In contrast to infant cases, MLL -R leukemia in older children had more somatic mutations (mean of 6.5 mutations/case versus 1.3 mutations/case, P = 7.15 × 10(-5)) and had frequent mutations (45%) in epigenetic regulators, a category of genes that, with the exception of MLL , was rarely mutated in infant MLL -R ALL .
25730765
2015
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400
Biomarker
CTD_human
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.
25730765
2015
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Childhood Acute Lymphoblastic Leukemia
0.400
Biomarker
CTD_human
MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL.
24736461
2014
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.400
Biomarker
CTD_human
Acute lymphoblastic leukemia in infants (< 1 year-of-age) is characterized by a high incidence of MLL rearrangements.
24736461
2014
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Lymphoid leukemia
0.400
Biomarker
CTD_human
Modeling the initiation and progression of human acute leukemia in mice.
17463288
2007
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Myeloid Leukemia
0.400
Biomarker
CTD_human
Modeling the initiation and progression of human acute leukemia in mice.
17463288
2007
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
leukemia
0.400
Biomarker
CTD_human
A single case is described of congenital leukaemia with 11q23/MLL rearrangement in a preterm female newborn.
12937054
2003
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
leukemia
0.400
Biomarker
CTD_human
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
11731795
2002
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute monocytic leukemia
0.400
Biomarker
CTD_human
Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.
8282816
1994
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Myeloid Leukemia
0.400
Biomarker
CTD_human
Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.
8282816
1994
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute myelomonocytic leukemia
0.400
Biomarker
CTD_human
Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.
8282816
1994
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Malignant neoplasm of prostate
0.370
Biomarker
CTD_human
The long tail of oncogenic drivers in prostate cancer.
29610475
2018
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Liver carcinoma
0.360
Biomarker
CTD_human
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators.
22634756
2012
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Malignant neoplasm of stomach
0.330
Biomarker
CTD_human
Frequent mutations in chromatin remodeling genes (ARID1A, MLL3 and MLL ) also occurred in 47% of the gastric cancers .
22484628
2012
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute Myeloid Leukemia, M1
0.320
Biomarker
CTD_human
The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias.
26237430
2015
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute Myeloid Leukemia (AML-M2)
0.320
Biomarker
CTD_human
The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias.
26237430
2015
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute Myeloid Leukemia, M1
0.320
Biomarker
CTD_human
MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).
10339604
1999
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute Myeloid Leukemia (AML-M2)
0.320
Biomarker
CTD_human
MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).
10339604
1999
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Malignant neoplasm of urinary bladder
0.310
Biomarker
CTD_human
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder.
21822268
2011
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Bladder Neoplasm
0.310
Biomarker
CTD_human
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder.
21822268
2011
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute erythroleukemia
0.300
Biomarker
CTD_human
Genomic subtyping and therapeutic targeting of acute erythroleukemia.
30926971
2019
×
Entrez Id:
4297
Gene Symbol:
KMT2A
KMT2A
Acute erythroleukemia - M6a subtype
0.300
Biomarker
CTD_human
Genomic subtyping and therapeutic targeting of acute erythroleukemia.
30926971
2019